INSIGHTS Trademark

Trademark Overview


On Friday, February 9, 2024, a trademark application was filed for INSIGHTS with the United States Patent and Trademark Office. The USPTO has given the INSIGHTS trademark a serial number of 98400249. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 4, 2024. This trademark is owned by FRESENIUS MEDICAL CARE HOLDINGS, INC.. The INSIGHTS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Sensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data; for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages

Cloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
insights

General Information


Serial Number98400249
Word MarkINSIGHTS
Filing DateFriday, February 9, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word "inSights" with "Sights" in a bold font.
Pseudo MarkIN SIGHTS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesSensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data; for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
Goods and ServicesCloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFRESENIUS MEDICAL CARE HOLDINGS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451

Trademark Events


Event DateEvent Description
Friday, February 9, 2024NEW APPLICATION ENTERED
Wednesday, September 4, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 4, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED